Literature DB >> 10705229

CASCADE: a European collaborative study on vascular determinants of brain lesions. Study design and objectives.

L J Launer1, M Oudkerk, L G Nilsson, A Alperovitch, K Berger, M M Breteler, R Fuhrer, S Giampaoli, A Nissinen, A Pajak, S Sans, R Schmidt, A Hofman.   

Abstract

Dementia is a highly prevalent disease that may have a cardiovascular component. White matter lesions and brain atrophy (brain abnormalities) are prevalent in dementia cases and might form part of the anatomical basis for the disease. We designed a multi-centre study, CASCADE (Cardiovascular Determinants of Dementia), to examine long-term (10-20 years) and short-term (5 years) cardiovascular risk factors for, and the cognitive consequence of, brain abnormalities. White matter lesions and atrophy are measured with magnetic resonance imaging. Cognitive function is measured with nine tests of memory and executive function. The studies included in CASCADE were ongoing and geographically spread throughout Europe to capture the cardiovascular risk gradient. In each study, a random sample of at least 100 subjects aged 65-75 years was selected who participated in the previous research examinations conducted by the respective centres. The objectives and design of the CASCADE project are described. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10705229     DOI: 10.1159/000026246

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

1.  Albuminuria and cognitive decline in people with diabetes and normal renal function.

Authors:  Joshua I Barzilay; James F Lovato; Anne M Murray; Jeff Williamson; Faramaz Ismail-Beigi; Diane Karl; Vasilios Papademetriou; Lenore J Launer
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  Cognitive Performance Does not Limit Physical Activity Participation in the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P).

Authors:  K F Reid; M P Walkup; J A Katula; K M Sink; S Anton; R Axtell; D R Kerwin; A C King; F Kramer; M E Miller; V Myers; C Rosano; S A Studenski; O L Lopez; J Verghese; R A Fielding; J Williamson
Journal:  J Prev Alzheimers Dis       Date:  2017

3.  Structural brain changes and all-cause mortality in the elderly population-the mediating role of inflammation.

Authors:  Uta Hanning; Andreas Roesler; Annette Peters; Klaus Berger; Bernhard T Baune
Journal:  Age (Dordr)       Date:  2016-10-20

4.  Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study.

Authors:  Jeff D Williamson; Mark Espeland; Stephen B Kritchevsky; Anne B Newman; Abby C King; Marco Pahor; Jack M Guralnik; Leslie A Pruitt; Michael E Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-24       Impact factor: 6.053

5.  Single and combined effects of cerebral white matter lesions and lacunar infarctions on cognitive function in an elderly population.

Authors:  Bernard T Baune; Andreas Roesler; Stefan Knecht; Klaus Berger
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-20       Impact factor: 6.053

Review 6.  Hypertension and aging.

Authors:  Thomas W Buford
Journal:  Ageing Res Rev       Date:  2016-02-01       Impact factor: 10.895

7.  The Rotterdam Scan Study: design and update up to 2012.

Authors:  M Arfan Ikram; Aad van der Lugt; Wiro J Niessen; Gabriel P Krestin; Peter J Koudstaal; Albert Hofman; Monique M B Breteler; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2011-10-16       Impact factor: 8.082

8.  The Rotterdam Scan Study: design update 2016 and main findings.

Authors:  M Arfan Ikram; Aad van der Lugt; Wiro J Niessen; Peter J Koudstaal; Gabriel P Krestin; Albert Hofman; Daniel Bos; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-12-09       Impact factor: 8.082

9.  Studying variability in human brain aging in a population-based German cohort-rationale and design of 1000BRAINS.

Authors:  Svenja Caspers; Susanne Moebus; Silke Lux; Noreen Pundt; Holger Schütz; Thomas W Mühleisen; Vincent Gras; Simon B Eickhoff; Sandro Romanzetti; Tony Stöcker; Rüdiger Stirnberg; Mehmet E Kirlangic; Martina Minnerop; Peter Pieperhoff; Ulrich Mödder; Samir Das; Alan C Evans; Karl-Heinz Jöckel; Raimund Erbel; Sven Cichon; Markus M Nöthen; Dieter Sturma; Andreas Bauer; N Jon Shah; Karl Zilles; Katrin Amunts
Journal:  Front Aging Neurosci       Date:  2014-07-14       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.